Timothy S. Ernst - Sep 1, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Signature
/s/ Timothy S. Ernst
Stock symbol
BIO
Transactions as of
Sep 1, 2022
Transactions value $
-$42,790
Form type
4
Date filed
9/6/2022, 01:52 PM
Previous filing
Sep 9, 2021
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +253 +11.51% $0.00 2.45K Sep 1, 2022 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$42.8K -88 -3.59% $486.25 2.36K Sep 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +1.39K $0.00 1.39K Sep 1, 2022 Bio-Rad A Common Stock 1.39K $0.00 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -253 -24.98% $0.00 760 Sep 1, 2022 Bio-Rad A Common Stock 253 $0.00 Direct F3, F5

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 13.9013, 1.0911, 13.6432, and 15.5238 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2021, 12/31/2021, 03/31/2022 and 06/30/2022, respectively.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5 On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.